Intelligent Medicine Acquisition Corp. Warrant
IQMDW
IQMDW was delisted on the 26th of April, 2023.
16 hedge funds and large institutions have $4.11M invested in Intelligent Medicine Acquisition Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$394K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$151K |
| 3 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$142K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$126K |
| 5 |
SC
Sculptor Capital
New York
|
+$126K |
Top Sellers
IQMDW Hedge Fund Activity: Q4 2021 in Review
16 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) for Q4 2021, worth a combined $4.11M.
Buyers outnumbered sellers: 16 funds opened new IQMDW positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $394K.
- 16 institutional investors held Intelligent Medicine Acquisition Corp. Warrant (IQMDW) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $4.11M of Intelligent Medicine Acquisition Corp. Warrant stock for Q4 2021.
- 16 funds opened new Intelligent Medicine Acquisition Corp. Warrant positions in Q4 2021 and 0 closed out, a net change of +16 holders.
- The largest Intelligent Medicine Acquisition Corp. Warrant buyer in Q4 2021 was Saba Capital Management, an estimated $394K added.
Based on aggregated 13F filings for Q4 2021.